{"name": "KineMed",
 "permalink": "kinemed",
 "crunchbase_url": "http://www.crunchbase.com/company/kinemed",
 "homepage_url": "http://www.kinemed.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1999,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "510.655.6525",
 "description": "Translational Medicine",
 "created_at": "Thu Sep 24 11:44:27 UTC 2009",
 "updated_at": "Thu Sep 24 11:50:19 UTC 2009",
 "overview": "\u003Cp\u003EKineMed is a leader in Translational Medicine (TM) and Personalized Medicine (PM).\u003C/p\u003E\n\n\u003Cp\u003ETM \u0026amp; PM are two keys to unlocking future growth in the pharmaceutical sector. After several spectacular decades of astonishing R\u0026amp;D productivity associated with impressive value creation, pharmaceutical companies are fighting for their futures. This reflects many challenges, amongst which one of the biggest and most crucial is flagging R\u0026amp;D productivity. TM \u0026amp; PM have the potential to revitalize the pharmaceutical sector by driving R\u0026amp;D productivity.\nLeveraging ground-breaking science from the laboratories of Professor Marc Hellerstein, M.D., Ph.D., KineMed has invested a decade and over $60 MM to create state-of-the-art capabilities in Translational and Personalized Medicine applicable across many therapy areas.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       60],
      "assets/images/resized/0006/0728/60728v1-max-150x150.png"],
     [[223,
       90],
      "assets/images/resized/0006/0728/60728v1-max-250x250.png"],
     [[223,
       90],
      "assets/images/resized/0006/0728/60728v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$15M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://venturebeat.com/2007/08/03/kinemed-raises-15m-for-lou-gehrigs-disease/",
    "source_description": "KineMed raises $15M for Lou Gehrig\u00e2\u20ac\u2122s disease",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 8,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Stanford Financial Group",
         "permalink": "stanford-financial-group",
         "image":
          {"available_sizes":
            [[[150,
               10],
              "assets/images/resized/0005/8537/58537v1-max-150x150.png"],
             [[250,
               17],
              "assets/images/resized/0005/8537/58537v1-max-250x250.png"],
             [[450,
               31],
              "assets/images/resized/0005/8537/58537v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "5980 Horton Street",
    "address2": "Suite 400",
    "zip_code": "94608",
    "city": "Emeryville",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        138],
       "assets/images/resized/0006/0729/60729v1-max-150x150.jpg"],
      [[250,
        230],
       "assets/images/resized/0006/0729/60729v1-max-250x250.jpg"],
      [[450,
        414],
       "assets/images/resized/0006/0729/60729v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}